Reported Tuberculosis in the United States, 2017

Return to Main Menu

Table 45. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility Results, by Resistance to Isoniazid or Multidrug Resistance: Reporting Areas, 2017

Table 45. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility Results, by Resistance to Isoniazid or Multidrug Resistance: Reporting Areas, 2017
Reporting Area Total Culture Positive Cases Cases with Initial Drug-Susceptibility Testing Performed1 Resistance2
Isoniazid1 Isoniazid and Rifampin1
No. (%) No. (%) No. (%)
United States 7,126 6,531 (91.7) 608 (9.3) 123 (1.9)
Alabama 97 94 (96.9) 5 (5.3) 1 (1.1)
Alaska 45 45 (100.0) 6 (13.3) 1 (2.2)
Arizona 150 150 (100.0) 16 (10.7) 4 (2.7)
Arkansas 43 42 (97.7) 3 (7.1) 2 (4.8)
California 1,703 1,648 (96.8) 156 (9.5) 30 (1.8)
Colorado 57 57 (100.0) 5 (8.8) 0 (0.0)
Connecticut 51 50 (98.0) 5 (10.0) 1 (2.0)
Delaware 10 6 (60.0) 1 (16.7) 1 (16.7)
District of Columbia 28 28 (100.0) 3 (10.7) 1 (3.6)
Florida 445 423 (95.1) 28 (6.6) 6 (1.4)
Georgia 202 175 (86.6) 16 (9.1) 3 (1.7)
Hawaii 92 88 (95.7) 12 (13.6) 3 (3.4)
Idaho 6 6 (100.0) 0 (0.0) 0 (0.0)
Illinois 251 242 (96.4) 23 (9.5) 1 (0.4)
Indiana 67 66 (98.5) 5 (7.6) 3 (4.5)
Iowa 36 36 (100.0) 4 (11.1) 1 (2.8)
Kansas 26 25 (96.2) 3 (12.0) 0 (0.0)
Kentucky 57 57 (100.0) 4 (7.0) 2 (3.5)
Louisiana 111 97 (87.4) 7 (7.2) 2 (2.1)
Maine 14 14 (100.0) 1 (7.1) 1 (7.1)
Maryland 156 155 (99.4) 13 (8.4) 2 (1.3)
Massachusetts 161 160 (99.4) 29 (18.1) 5 (3.1)
Michigan 89 89 (100.0) 8 (9.0) 0 (0.0)
Minnesota 141 141 (100.0) 22 (15.6) 9 (6.4)
Mississippi 43 43 (100.0) 2 (4.7) 0 (0.0)
Missouri 55 50 (90.9) 4 (8.0) 1 (2.0)
Montana 3 3 (100.0) 1 (33.3) 0 (0.0)
Nebraska 18 11 (61.1) 5 (45.5) 1 (9.1)
Nevada 66 65 (98.5) 5 (7.7) 0 (0.0)
New Hampshire 14 14 (100.0) 2 (14.3) 1 (7.1)
New Jersey 231 224 (97.0) 17 (7.6) 3 (1.3)
New Mexico 32 32 (100.0) 4 (12.5) 0 (0.0)
New York State3 142 138 (97.2) 9 (6.5) 2 (1.4)
New York City 505 494 (97.8) 55 (11.1) 15 (3.0)
North Carolina 172 171 (99.4) 6 (3.5) 2 (1.2)
North Dakota 10 8 (80.0) 2 (25.0) 0 (0.0)
Ohio 106 106 (100.0) 7 (6.6) 2 (1.9)
Oklahoma 39 39 (100.0) 8 (20.5) 3 (7.7)
Oregon 48 47 (97.9) 7 (14.9) 0 (0.0)
Pennsylvania 153 139 (90.8) 8 (5.8) 0 (0.0)
Rhode Island 8 8 (100.0) 0 (0.0) 0 (0.0)
South Carolina 83 80 (96.4) 7 (8.8) 1 (1.3)
South Dakota 12 12 (100.0) 1 (8.3) 0 (0.0)
Tennessee 99 99 (100.0) 8 (8.1) 0 (0.0)
Texas 851 469 (55.1) 32 (6.8) 6 (1.3)
Utah 23 23 (100.0) 1 (4.3) 0 (0.0)
Vermont 3 3 (100.0) 0 (0.0) 0 (0.0)
Virginia 149 149 (100.0) 14 (9.4) 4 (2.7)
Washington 170 157 (92.4) 22 (14.0) 3 (1.9)
West Virginia 13 13 (100.0) 1 (7.7) 0 (0.0)
Wisconsin 40 40 (100.0) 5 (12.5) 0 (0.0)
Wyoming 0 0 0 0
American Samoa4 1 0 (0.0) 0 0
Fed. States of Micronesia4 44 43 (97.7) 0 (0.0) 0 (0.0)
Guam4 57 52 (91.2) 3 (5.8) 1 (1.9)
Marshall Islands4 72 71 (98.6) 3 (4.2) 0 (0.0)
N. Mariana Islands4 20 11 (55.0) 3 (27.3) 0 (0.0)
Puerto Rico4 30 30 (100.0) 0 (0.0) 0 (0.0)
Republic of Palau4 18 17 (94.4) 0 (0.0) 0 (0.0)
U.S. Virgin Islands4 0 0 0 0

1Patients tested to at least isoniazid and rifampin.
2Isolates may be resistant to other drugs. Overall U.S. percentage based on 52 reporting areas (50 states, New York City, and the District of Columbia).
3Excludes New York City.
4Not included in U.S. totals.
Note: Ellipses (…) indicate that the percentage cannot be calculated, and the denominator is 0.

Page last reviewed: October 22, 2018